Decoy Therapeutics Inc. (DCOY) Capital expenditures 2016–2025
Decoy Therapeutics Inc. (DCOY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$577,000FY2025 · since FY2016: $559,378 → $577,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $577,000 | — |
| FY2024 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $2,600 | — |
| FY2019 | $0 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $113,498 | -79.7% |
| FY2016 | $559,378 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice